It is well recognized that the immune system plays an essential role in tumor defense. The presence of tumor-infiltrating lymphocytes reflects an individual immunological response. In early breast cancer, the presence of TILs is associated with a more favorable outcome and response to therapy. In this review, we describe how TILs are assessed. Also, we discuss their role as prognostic and predictive biomarker in the neoadjuvant and adjuvant settings as well as in residual disease. Moreover, we discuss the possible implementation of TILs in daily clinical practice as well as in future clinical trials in order to fine tune prognosis and improve treatments.
Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer / C. Criscitiello, A. Esposito, D. Trapani, G. Curigliano. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - 50(2016), pp. 205-207.
Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer
C. Criscitiello;D. Trapani;G. Curigliano
Writing – Original Draft Preparation
2016
Abstract
It is well recognized that the immune system plays an essential role in tumor defense. The presence of tumor-infiltrating lymphocytes reflects an individual immunological response. In early breast cancer, the presence of TILs is associated with a more favorable outcome and response to therapy. In this review, we describe how TILs are assessed. Also, we discuss their role as prognostic and predictive biomarker in the neoadjuvant and adjuvant settings as well as in residual disease. Moreover, we discuss the possible implementation of TILs in daily clinical practice as well as in future clinical trials in order to fine tune prognosis and improve treatments.File | Dimensione | Formato | |
---|---|---|---|
pdf.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
231.28 kB
Formato
Adobe PDF
|
231.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.